Please login to the form below

Not currently logged in
Email:
Password:

BMS appoints leading oncologist to board

Thomas Lynch is director of Yale Cancer Center

BMS Thomas LynchBristol-Myers Squibb (BMS) has appointed one of the world's leading oncologists to its board of directors.

Dr Thomas Lynch, who is currently director of the Yale Cancer Center, will join the pharma company's science and technology committee.

In addition to his role at Yale, Dr Lynch is also physician-in-chief at the Smilow Cancer Hospital at Yale-New Haven in the US, as well as professor of medical oncology at the same hospital.

Lamberto Andreotti, CEO of BMS, praised both Dr Lynch's work in cancer as well as his business leadership.

“As we advance our work in immuno-oncology and build our leadership position in oncology, his guidance and scientific and business perspectives will be invaluable,” said Andreotti.

Prior to his current roles at Yale, Dr Lynch was a professor of medicine at Harvard Medical School and chief of haematology and oncology at Massachusetts General Hospital (MGH) Cancer Center.

He also served as director of the Center for Thoracic Cancers at MGH and director of medical oncology at MGH Thoracic Oncology Center.

13th December 2013

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Star

We're passionate about helping our clients to make a real commercial impact. We achieve this through our unique approach to...

Latest intelligence

The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Escaping the spin cycle of sub-optimal launch
...

Infographics